{
  "docId": "019de075-2dc4-7413-a6ea-ecd3ab0cc295",
  "docSlug": "e0f48061a961c5e04d59dc15b9a47e3c",
  "documentTitle": "MindMed | Investor Presentation Deck | 36 slides",
  "authorId": "mindmed",
  "authorName": "MindMed",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 15,
  "pageCount": 36,
  "prevPage": 14,
  "nextPage": 16,
  "slideType": "appendix_methodology",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "The slide uses a timeline-based process diagram to illustrate the clinical trial structure.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-2dc4-7413-a6ea-ecd3ab0cc295/15",
  "deckHref": "/decks/019de075-2dc4-7413-a6ea-ecd3ab0cc295",
  "deckJsonHref": "/decks/019de075-2dc4-7413-a6ea-ecd3ab0cc295.json",
  "deckAnchorHref": "/decks/019de075-2dc4-7413-a6ea-ecd3ab0cc295#slide-15",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.4,
        "x": 0.15,
        "y": 0.25
      },
      "kind": "diagram",
      "text": "Clinical trial timeline showing prep, dosing, and follow-up weeks -5 to 12",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b43d8a69-f62f-48e4-a3e2-595e5f9b970b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.25,
        "x": 0.68,
        "y": 0.25
      },
      "kind": "list",
      "text": "Key entry criteria and additional endpoints for the study",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "04a10848-c48c-4261-a09d-509611ad542d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.6,
        "x": 0.05,
        "y": 0.85
      },
      "kind": "source-note",
      "text": "Source: MindMed internal study documents. Abbreviations defined.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "02ddb5a3-9347-4b2a-80fb-f7546dd13838",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.6,
        "x": 0.05,
        "y": 0.09
      },
      "kind": "title",
      "text": "Study design seeks to evaluate dose-responsive effects and identify optimal dose for pivotal clinical trials",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "99b3ed2e-6796-4a77-9a84-ee5fc640f82e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.05,
        "y": 0.03
      },
      "kind": "title",
      "text": "MM-120 | Phase 2b Generalized Anxiety Disorder (GAD)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4d5362ac-808b-466f-9f11-4e9e7b404fa6",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "clinical-trial-design",
      "slug": null,
      "matchId": "bc47362c-b17f-4ef6-8b06-c5286a84d269",
      "evidence": "Timeline and arm-based study structure",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}